Adi Gazdar, M.D., receives funding from the U.S. Department of Defense

Adi Gazdar, M.D., recently received a $422,666 grant from the U.S. Department of Defense to support his research regarding blood-based biomarkers for lung cancer early detection and evaluation of CT-based lesions.

Dr. Gazdar, holder of the W. Ray Wallace Distinguished Chair in Molecular Pathology Research, is a Professor in the Department of Pathology, as well as the Hamon Center for Therapeutic Oncology. He has also been named by the Institute for Scientific Information a list of the world's most cited authors – comprising less than one half of one percent of all publishing researchers, based on the important scientific developments of the last two decades.

Congratulations, Dr. Gazdar.

Share: